Highlights in Esophageal Research From ACG 2022

Suneel D. Kamath, MD


November 15, 2022

Highlights in esophageal diseases presented at the American College of Gastroenterology Scientific Sessions 2022 are discussed by Dr Suneel Kamath of the Cleveland Clinic.

Dr Kamath outlines the latest data from the LIBERTY-EoE-TREET trial showing that 6 months of weekly dupilumab improves all outcomes of eosinophilic esophagitis.

He goes on to describe results from the Veterans Affairs Achalasia Cohort that indicate a significantly increased risk for esophageal cancer is associated with achalasia.

Next, Dr Kamath outlines results of a study showing predictive values of various noninvasive scoring systems for varices to identify patients who need endoscopy or can go without it.

He closes by reporting results of a study showing that on-demand vonoprazan provides rapid, sustained relief of nonerosive reflux disease.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.